Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Pharmacotherapy|May 16, 2000
Pharmacokinetics and pharmacodynamics of ceftizoxime in patients with dosages adjusted for renal functionM M Neuhauser, P S McKinnon, E Hershberger, et al.
Pharmacotherapy|November 11, 1999
Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycosideK R Murry, P S McKinnon, B Mitrzyk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremiaThomas P Lodise, Peggy S McKinnon, Linda Swiderski, et al.
Neuropharmacology|November 29, 2011
Profound reduction in sensitivity to the aversive effects of methamphetamine in mice bred for high methamphetamine intakeShkelzen Shabani, Carrie S McKinnon, Christopher L Cunningham, et al.
Behavioural Brain Research|September 3, 2013
Unique genetic factors influence sensitivity to the rewarding and aversive effects of methamphetamine versus cocaineNoah R Gubner, Cheryl Reed, Carrie S McKinnon, et al.
Clinical Pharmacokinetics|February 1, 1995
The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agentsJ M Hyatt, P S McKinnon, G S Zimmer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2002
Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma centerThomas P Lodise, Peggy S McKinnon, Vincent H Tam, et al.
Pageof 10